CIAM
IRWD icon

Caitong International Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Caitong International Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Buy
3,076
+2,554
+489% +$9.84K ﹤0.01% 1092
2026
Q1 		$1.83K Buy
+522
New +$2.14K ﹤0.01% 1259
2025
Q1 		– Sell
-627
Closed -$2.78K – 2351
2024
Q4 		$2.78K Buy
+627
New +$2.54K ﹤0.01% 1126

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Caitong International Asset Management's IRWD Position: Q2 2026 in Review

Caitong International Asset Management increased its Ironwood Pharmaceuticals (IRWD) stake by 489% in Q2 2026, buying an estimated $9.84K and bringing the position to 3,076 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Caitong International Asset Management first reported a position in IRWD in Q4 2024 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Caitong International Asset Management held 3,076 shares of Ironwood Pharmaceuticals worth $12.9K as of Q2 2026.
  • Caitong International Asset Management bought 2,554 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $9.84K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1092 holding.
  • Caitong International Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.